Want to join the conversation?
$AVAV expects 2Q17 and remainder of FY17 GMs to increase and move closer to historical levels after adjusting for incremental sustaining engineering expense. Funded backlog at end 1Q17 fell about 16% to $74.7MM versus end 1Q16, and is expected to be about 51% for FY17.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.